(Health-NewsWire.Net, October 11, 2017 ) According to the report North America Radiotherapy Market, published by Market Data Forecast, the Market was worth USD 1,798 million in 2016 and estimated to be growing at a CAGR of 5.54%, to reach USD 2,355 million by 2021. North America is the utmost vibrant, extremely competitive and the leading market for radiotherapy devices globally. The market growth is considerably higher in North America since it is continuously inclined to the usage of novel technologies.
Radiation therapy practices high energy radiation on directed cells and cell progression to stop them from growing and distributing. Radiations are mainly from an external machine or from implants i.e. internal machine which is placed near the tumours. This technique is widely used for the treatment of cancerous tumour, benign tumours and other conditions like thyroid disease and some blood disorders.
Browse market data tables and in-depth TOC of the North America Radiotherapy Industry to 2021 @ http://www.marketdataforecast.com/market-reports/north-america-radiotherapy-market-816/
The North American Radiotherapy Market is driven by quickly altering cancer treatment technology and increasing number of cancer patients. Growth is also driven by technological advancements in biological and molecular imaging techniques that permit radiotherapy to be progressively personalized for patient needs. Emerging healthy reimbursement plans and untapped market in few areas are also few factors fuelling the growth of radiotherapy market. Major factors inhibiting the growth of the market are healthcare expenditure and alternative treatment procedures.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/north-america-radiotherapy-market-816/request-sample
The North America radiotherapy market is segmented on the basis of type into External beam radiation therapy, internal beam radiation therapy and systemic radiation therapy. External beam radiation therapy is sub segmented into Intensity-modulated radiation therapy (IMRT), Image-guided radiation therapy (IGRT), Tomotherapy, Stereotactic radiosurgery, Stereotactic body radiation therapy and Proton therapy. Based on application the market is segregated into Skin & Lip Cancer, Head & Neck Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer and Spine Cancer. On the basis of equipment type market is bifurcated into Linear accelerators, Radiation therapy simulators and Treatment planning systems. The prostate cancer application segment is estimated to hold the largest share in both external beam radiotherapy market along with internal radiotherapy market.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/north-america-radiotherapy-market-816/inquire
Based on geography the market is analysed under various regions namely, USA and Canada. USA accounts for the highest number of shares globally followed by Canada.
Nordion Inc. (Canada), RaySearch Laboratories AB (Sweden), Ion Beam Applications SA (Belgium), C. R. Bard Inc. (U.S.), Mevion Medical Systems Inc. (U.S.), Varian Medical Systems Inc. (U.S.), IsoRay Medical Inc. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), and Mitsubishi Electric Corporation (Japan) are the key players in the radiotherapy market.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|